Related references
Note: Only part of the references are listed.Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Interpreting Diagnostic Tests for SARS-CoV-2
Nandini Sethuraman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Severe Coronavirus Disease-2019 in Children and Young Adults in the Washington, DC, Metropolitan Region
Roberta L. DeBiasi et al.
JOURNAL OF PEDIATRICS (2020)
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
Janice Hopkins Tanne
BMJ-BRITISH MEDICAL JOURNAL (2020)
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
Kelvin Kai-Wang To et al.
LANCET INFECTIOUS DISEASES (2020)
Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020
Stephanie Bialek et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Epidemiology of COVID-19 Among Children in China
Yuanyuan Dong et al.
PEDIATRICS (2020)
Upper Respiratory Infections and Airway Adverse Events in Pediatric Procedural Sedation
Michael D. Mallory et al.
PEDIATRICS (2017)
Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
J. van Griensven et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Hyperimmune IV Immunoglobulin Treatment A Multicenter Double-Blind Randomized Controlled Trial for Patients With Severe 2009 Influenza A(H1N1) Infection
Ivan F. N. Hung et al.
CHEST (2013)
Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2011)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
KM Yeh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
A serological survey on neutralizing antibody titer of SARS convalescent sera
JS Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Risk factors for adverse postoperative outcomes in children presenting for cardiac surgery with upper respiratory tract infections
S Malviya et al.
ANESTHESIOLOGY (2003)
Risk factors for perioperative adverse respiratory events in children with upper respiratory tract infections
AR Tait et al.
ANESTHESIOLOGY (2001)
Clinical predictors of anaesthetic complications in children with respiratory tract infections
SJ Parnis et al.
PAEDIATRIC ANAESTHESIA (2001)
Share Paper
